APA (7th ed.) Citation

H, J., T, Y., H, H., S, Y., Y, M., Y, S., . . . Y, O. (2022). Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab. Cancer immunology, immunotherapy : CII, 71(2), 387. https://doi.org/10.1007/s00262-021-02997-2

Chicago Style (17th ed.) Citation

H, Jo, et al. "Prognostic Significance of Cachexia in Advanced Non-small Cell Lung Cancer Patients Treated with Pembrolizumab." Cancer Immunology, Immunotherapy : CII 71, no. 2 (2022): 387. https://doi.org/10.1007/s00262-021-02997-2.

MLA (9th ed.) Citation

H, Jo, et al. "Prognostic Significance of Cachexia in Advanced Non-small Cell Lung Cancer Patients Treated with Pembrolizumab." Cancer Immunology, Immunotherapy : CII, vol. 71, no. 2, 2022, p. 387, https://doi.org/10.1007/s00262-021-02997-2.